Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001060340 | SCV001225021 | pathogenic | Familial aplasia of the vermis; Meckel-Gruber syndrome; Nephronophthisis | 2022-10-30 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 855145). This variant has not been reported in the literature in individuals affected with CEP290-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change creates a premature translational stop signal (p.Gln2150Lysfs*8) in the CEP290 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CEP290 are known to be pathogenic (PMID: 16909394, 17345604, 20690115). |
Institute of Medical Genetics and Applied Genomics, |
RCV001268817 | SCV001448007 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002505627 | SCV002807168 | likely pathogenic | Leber congenital amaurosis 10; Meckel syndrome, type 4; Senior-Loken syndrome 6; Joubert syndrome 5; Bardet-Biedl syndrome 14 | 2021-10-29 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003467807 | SCV004214859 | likely pathogenic | Bardet-Biedl syndrome 14 | 2023-10-17 | criteria provided, single submitter | clinical testing |